See more : Grand Pacific Petrochemical Corporation (1312.TW) Income Statement Analysis – Financial Results
Complete financial analysis of Demant A/S (WILYY) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Demant A/S, a leading company in the Medical – Devices industry within the Healthcare sector.
You may be interested
- Cyient DLM Limited (CYIENTDLM.NS) Income Statement Analysis – Financial Results
- Global Capital Partners Inc. (GCPL) Income Statement Analysis – Financial Results
- G2 Goldfields Inc. (GTWO.V) Income Statement Analysis – Financial Results
- Oatly Group AB (OTLY) Income Statement Analysis – Financial Results
- Deep Polymers Limited (DEEP.BO) Income Statement Analysis – Financial Results
Demant A/S (WILYY)
About Demant A/S
Demant A/S, a hearing healthcare and audio technology company, develops, manufactures, and sells products and equipment to enhance people's hearing in Europe, North America, the Pacific, Asia, and internationally. It operates in two segments, Hearing Healthcare and Communications. The Hearing Healthcare segment offers hearing implants and aids, hearing care, and diagnostic products. The Communications segment provides headsets for collaborative work and gaming markets under the EPOS brand name. The company was formerly known as William Demant Holding A/S and changed its name to Demant A/S in March 2019. Demant A/S was founded in 1904 and is headquartered in Smørum, Denmark.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 22.44B | 19.71B | 18.39B | 14.47B | 14.95B | 13.94B | 13.19B | 12.00B | 10.67B | 9.35B | 9.21B | 8.56B | 8.04B | 6.89B | 5.70B | 5.37B | 5.49B | 5.09B | 4.52B | 4.30B | 3.87B | 3.92B |
| Cost of Revenue | 5.90B | 5.04B | 4.63B | 4.28B | 3.62B | 3.15B | 3.16B | 2.97B | 2.77B | 2.53B | 2.54B | 2.43B | 2.26B | 1.93B | 1.67B | 1.65B | 1.03B | 938.61M | 878.38M | 971.36M | 1.35B | 1.42B |
| Gross Profit | 16.54B | 14.67B | 13.75B | 10.19B | 11.33B | 10.78B | 10.03B | 9.03B | 7.90B | 6.81B | 6.67B | 6.13B | 5.78B | 4.96B | 4.03B | 3.73B | 4.46B | 4.15B | 3.64B | 3.33B | 2.52B | 2.51B |
| Gross Profit Ratio | 73.72% | 74.44% | 74.80% | 70.45% | 75.77% | 77.38% | 76.02% | 75.24% | 74.03% | 72.90% | 72.45% | 71.62% | 71.84% | 71.94% | 70.77% | 69.33% | 81.26% | 81.54% | 80.58% | 77.42% | 65.15% | 63.85% |
| Research & Development | 1.41B | 1.31B | 1.35B | 1.26B | 1.12B | 1.01B | 919.00M | 839.00M | 763.00M | 680.00M | 664.00M | 652.00M | 633.00M | 615.30M | 576.00M | 532.90M | 215.87M | 196.85M | 166.35M | 114.32M | 294.89M | 272.18M |
| General & Administrative | 1.14B | 1.04B | 937.00M | 840.00M | 851.00M | 761.00M | 727.00M | 676.00M | 613.00M | 560.00M | 551.00M | 515.00M | 482.00M | 449.00M | 380.80M | 2.15B | -608.24M | -640.29M | -581.98M | -571.65M | 242.05M | 263.35M |
| Selling & Marketing | 9.92B | 9.23B | 8.24B | 7.07B | 7.42B | 6.62B | 6.10B | 5.65B | 4.69B | 3.88B | 3.67B | 3.32B | 2.96B | 2.47B | 1.93B | 0.00 | 843.50M | 746.14M | 671.75M | 651.21M | 1.13B | 1.16B |
| SG&A | 11.06B | 10.27B | 9.18B | 7.91B | 8.27B | 7.38B | 6.82B | 6.33B | 5.30B | 4.44B | 4.22B | 3.83B | 3.44B | 2.92B | 2.31B | 2.15B | 235.26M | 105.85M | 89.77M | 79.56M | 1.37B | 1.42B |
| Other Expenses | -69.00M | 0.00 | -99.00M | 0.00 | -100.00M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -6.00M | -5.70M | 0.00 | -178.90M | 2.01M | 3.08M | 3.63M | 3.31M | -1.68M | -607.00K |
| Operating Expenses | 12.40B | 11.58B | 10.43B | 9.17B | 9.29B | 8.39B | 7.74B | 7.17B | 6.07B | 5.12B | 4.89B | 4.49B | 4.07B | 3.53B | 2.89B | 2.51B | 3.26B | 2.88B | 2.56B | 2.33B | 1.67B | 1.70B |
| Cost & Expenses | 18.30B | 16.62B | 15.06B | 13.44B | 12.91B | 11.54B | 10.90B | 10.14B | 8.84B | 7.65B | 7.43B | 6.91B | 6.33B | 5.46B | 4.55B | 4.15B | 4.29B | 3.82B | 3.43B | 3.30B | 3.01B | 3.11B |
| Interest Income | 90.00M | 56.00M | 38.00M | 33.00M | 39.00M | 37.00M | 43.00M | 40.00M | 41.00M | 36.00M | 42.00M | 43.00M | 40.00M | 31.90M | 29.10M | 29.30M | 23.40M | 17.89M | 14.78M | 10.93M | 0.00 | 0.00 |
| Interest Expense | 559.00M | 195.00M | 109.00M | 117.00M | 163.00M | 98.00M | 69.00M | 59.00M | 40.00M | 40.00M | 54.00M | 98.00M | 143.00M | 148.00M | 123.40M | 168.70M | 102.51M | 65.29M | 51.93M | 49.34M | 0.00 | 0.00 |
| Depreciation & Amortization | 1.33B | 1.18B | 1.01B | 1.01B | 924.00M | 410.00M | 373.00M | 378.00M | 325.00M | 294.00M | 295.00M | 267.00M | 40.00M | 0.00 | 191.70M | -147.10M | 168.60M | 162.73M | 115.26M | 124.56M | 116.97K | 108.03K |
| EBITDA | 5.29B | 4.29B | 4.44B | 2.50B | 3.03B | 2.97B | 2.85B | 2.45B | 2.17B | 1.94B | 2.00B | 1.89B | 1.90B | 1.43B | 1.34B | 1.21B | 1.37B | 1.44B | 1.24B | 1.14B | 855.98M | 810.48M |
| EBITDA Ratio | 23.56% | 21.81% | 24.14% | 17.29% | 20.29% | 20.89% | 20.47% | 19.20% | 20.38% | 21.67% | 22.38% | 22.05% | 21.75% | 20.75% | 23.53% | 19.94% | 25.01% | 28.24% | 27.34% | 26.49% | 22.12% | 20.66% |
| Operating Income | 4.15B | 3.21B | 3.45B | 1.53B | 2.15B | 2.53B | 2.34B | 1.94B | 1.88B | 1.76B | 1.78B | 1.65B | 1.71B | 1.43B | 1.15B | 1.22B | 1.27B | 1.27B | 1.10B | 1.00B | 855.55M | 810.15M |
| Operating Income Ratio | 18.48% | 16.28% | 18.74% | 10.57% | 14.39% | 18.17% | 17.73% | 16.18% | 17.61% | 18.84% | 19.37% | 19.32% | 21.25% | 20.75% | 20.16% | 22.68% | 23.10% | 24.99% | 24.38% | 23.33% | 22.11% | 20.65% |
| Total Other Income/Expenses | -754.00M | -280.00M | -202.00M | -194.00M | -240.00M | -164.00M | -111.00M | -101.00M | -69.00M | -70.00M | -72.00M | -132.00M | -103.00M | -116.00M | -94.30M | -315.80M | -599.90M | -61.38M | -36.79M | -38.58M | -28.21M | -30.78M |
| Income Before Tax | 3.39B | 2.93B | 3.24B | 1.34B | 1.91B | 2.37B | 2.23B | 1.84B | 1.81B | 1.69B | 1.71B | 1.52B | 1.61B | 1.31B | 1.06B | 903.00M | 1.17B | 1.21B | 1.07B | 965.14M | 827.33M | 779.37M |
| Income Before Tax Ratio | 15.12% | 14.85% | 17.64% | 9.23% | 12.79% | 16.99% | 16.89% | 15.34% | 16.96% | 18.09% | 18.59% | 17.78% | 19.97% | 19.07% | 18.51% | 16.80% | 21.33% | 23.78% | 23.57% | 22.43% | 21.38% | 19.86% |
| Income Tax Expense | 839.00M | 651.00M | 715.00M | 202.00M | 444.00M | 538.00M | 468.00M | 377.00M | 370.00M | 364.00M | 401.00M | 370.00M | 407.00M | 326.00M | 260.20M | 220.60M | 276.30M | 308.47M | 275.44M | 248.24M | 209.05M | 200.80M |
| Net Income | 1.80B | 2.08B | 2.51B | 1.12B | 1.46B | 1.82B | 1.75B | 1.46B | 1.44B | 1.33B | 1.31B | 1.15B | 1.20B | 988.40M | 794.90M | 682.40M | 894.48M | 900.75M | 790.59M | 716.91M | 618.28M | 578.57M |
| Net Income Ratio | 8.00% | 10.57% | 13.67% | 7.75% | 9.78% | 13.08% | 13.30% | 12.16% | 13.46% | 14.19% | 14.23% | 13.48% | 14.91% | 14.34% | 13.94% | 12.70% | 16.30% | 17.71% | 17.48% | 16.66% | 15.98% | 14.75% |
| EPS | 11.44 | 9.31 | 10.92 | 4.70 | 6.06 | 7.42 | 6.92 | 5.62 | 5.31 | 4.83 | 4.65 | 4.05 | 2.06 | 1.69 | 1.36 | 1.16 | 1.48 | 1.44 | 1.22 | 1.07 | 0.88 | 0.79 |
| EPS Diluted | 8.04 | 9.31 | 10.92 | 4.70 | 6.06 | 7.42 | 6.93 | 5.61 | 5.36 | 4.84 | 4.65 | 4.07 | 2.06 | 1.69 | 1.36 | 1.16 | 1.48 | 1.44 | 1.22 | 1.07 | 0.88 | 0.79 |
| Weighted Avg Shares Out | 156.94M | 223.66M | 230.20M | 238.71M | 241.30M | 245.84M | 253.53M | 259.81M | 270.22M | 274.42M | 281.78M | 284.37M | 582.00M | 584.00M | 583.00M | 588.00M | 606.20M | 627.54M | 650.25M | 670.53M | 699.54M | 733.15M |
| Weighted Avg Shares Out (Dil) | 223.13M | 223.62M | 230.18M | 238.71M | 241.30M | 245.77M | 253.17M | 259.89M | 267.98M | 273.70M | 281.78M | 283.53M | 582.00M | 584.00M | 583.00M | 588.00M | 606.20M | 627.54M | 650.25M | 670.53M | 699.54M | 733.15M |
Best Momentum Stocks to Buy for March 26th
WILYY, VCTR and SBLK made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on March 26, 2023.
New Strong Buy Stocks for March 26th
SBLK, WILYY, TSCDY, UPWK and HENKY have been added to the Zacks Rank #1 (Strong Buy) List on March 26, 2023.
New Strong Buy Stocks for March 19th
AX, LI, GM, WILYY and DORM have been added to the Zacks Rank #1 (Strong Buy) List on March 19, 2024.
Best Momentum Stocks to Buy for March 11th
BWAY, WILYY and CRH made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on March 11, 2024.
New Strong Buy Stocks for March 11th
BWAY, WILLY, IDCC, BRKL and SBSI have been added to the Zacks Rank #1 (Strong Buy) List on March 11, 2024.
Best Momentum Stocks to Buy for March 7th
TOL, WILYY and LMAT made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on March 7, 2023.
New Strong Buy Stocks for March 7th
NSANY, TOL, AX, WILYY and TROW have been added to the Zacks Rank #1 (Strong Buy) List on March 7, 2023.
Best Momentum Stocks to Buy for March 4th
DFH, EME and WILLY made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on March 4, 2023.
New Strong Buy Stocks for March 4th
MUX, APAM, NTRS, WILYY and PERF have been added to the Zacks Rank #1 (Strong Buy) List on March 4, 2023.
Best Momentum Stocks to Buy for February 12th
AZEK, WILYY and RL made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on February 12, 2023.
Source: https://incomestatements.info
Category: Stock Reports